Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Phlai Capsule in Allergic Rhinitis
NCT04182919Phase 3Completed
- Sponsor
- Chulalongkorn University
- Start
- Jan 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zingiber cassumunar in allergic rhinitis (AR), sponsored by Chulalongkorn University. Started Jan 2020; status: completed.
02
Drugs
zingiber cassumunar
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT04182919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04182919.